Analysts Are Bullish on Top Healthcare Stocks: Owlet (OWLT), Exelixis (EXEL)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Owlet (OWLT – Research Report) and Exelixis (EXEL – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Owlet (OWLT)
In a report released today, Andrew Brackmann from William Blair maintained a Buy rating on Owlet. The company’s shares closed last Friday at $14.74.
According to TipRanks.com, Brackmann is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Owlet with a $14.50 average price target, a 0.8% upside from current levels. In a report issued on December 4, Northland Securities also maintained a Buy rating on the stock with a $15.50 price target.
See Insiders’ Hot Stocks on TipRanks >>
Exelixis (EXEL)
In a report issued on December 11, Akash Tewari from Jefferies maintained a Buy rating on Exelixis, with a price target of $46.00. The company’s shares closed last Friday at $40.88.
According to TipRanks.com, Tewari is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Exelixis with a $44.09 average price target, a 5.8% upside from current levels. In a report issued on December 5, Morgan Stanley also maintained a Buy rating on the stock with a $45.00 price target.
